Melanóma: vizsgálatok itt: Németország
37 of 48 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 18.. Ask the study team whether a trial fits you.
- 2. fázisTaking peopleA Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
- Where
- Frankfurt
- Életkor
- 18 év and over
- People
- 890 worldwide
- Run by
- Daiichi Sankyo
See details and how to joinNCT06172478 · EU 2023-507641-29-00 - 1/2. fázisTaking peopleA Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051)
- Where
- Muenster, Tuebingen
- Életkor
- 6 hónap to 17 év
- People
- 370 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT02332668 · EU 2022-501257-36-00 - 4. fázisFut, nem toborozDabrafenib and/or Trametinib Rollover Study
- Where
- Augsburg, Essen, Hamburg, Heidelberg, Mannheim
- Életkor
- 18 év to 100 év
- People
- 100 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT03340506 · EU 2023-509318-13-00 - 1. fázisFut, nem toborozSTART: Safety and Anti-Tumor Activity of PeptiCRAd-1 in Treatment of Cancer
- Where
- Berlin, Frankfurt am Main, Goettingen, Heidelberg, Tübingen
- Életkor
- 18 év and over
- People
- 15 worldwide
- Run by
- Valo Therapeutics Oy
See details and how to joinNCT05492682 · EU 2024-517580-23-00 - 2. fázisTaking peopleA Study of Navlimetostat (BMS-986504) Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)
- Where
- Hamburg, Heidelberg, Leipzig, Mainz, München, Würzburg
- Életkor
- 18 év and over
- People
- 254 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT07492680 - 3. fázisTaking peopleSUPRAME-ACTengine® IMA203 vs. Investigator's Choice of Treatment in Previously Treated, Unresectable or Metastatic Cutaneous Melanoma
- Where
- Berlin, Bonn, Cologne, Dresden, Erlangen, Essen, Frankfurt Am Main, Hamburg, Heidelberg, Leipzig, Mainz
- Életkor
- 18 év and over
- People
- 450 worldwide
- Run by
- Immatics US, Inc.
See details and how to joinNCT06743126 · EU 2024-517062-42-00 - 2. fázisNot yet taking people in NémetországDB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors
- Where
- Frankfurt am Main, Giessen
- Életkor
- 18 év and over
- People
- 750 worldwide
- Run by
- DualityBio Inc.
See details and how to joinNCT06953089 · EU 2025-523895-22-00 - 1/2. fázisTaking peopleA Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
- Where
- Berlin, Dresden, Heidelberg, Heilbronn, Leipzig, Mainz, Muenster
- Életkor
- 18 év and over
- People
- 680 worldwide
- Run by
- Daiichi Sankyo
See details and how to joinNCT06330064 · EU 2023-509632-26-00 - 1/2. fázisTaking peopleLong-Term Follow-up of Patients Treated With Miltenyi Cell and Gene Therapies
- Where
- Berlin, Cologne, Erlangen, Goettingen, Muenster, Munich, Tuebingen, Wuerzburg
- People
- 40
- Run by
- Miltenyi Biomedicine GmbH
See details and how to joinNCT06508775 · EU 2022-501648-14-00 - 1/2. fázisTaking peopleA Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors
- Where
- Berlin, Essen, Mainz, München, Tübingen
- Életkor
- 18 év and over
- People
- 1438 worldwide
- Run by
- BioNTech SE
See details and how to joinNCT07070232 · EU 2024-517261-16-00 - 2/3. fázisTaking peopleSafety and Efficacy of EIK1001 in Combo With Pembro Versus Placebo and Pembro as First-Line Therapy in Patients With Advanced Melanoma.
- Where
- Berlin, Buxtehude, Dresden, Erfurt, Erlangen, Gera, Halle (Saale), Hamburg, Kiel, Leipzig, Ludwigshafen Am Rhein, Luebeck, Magdeburg, Mainz, Mannheim, Marburg, Minden, Muenster, Nuremberg, Tuebingen, Wuerzburg
- Életkor
- 18 év and over
- People
- 740 worldwide
- Run by
- Eikon Therapeutics
See details and how to joinNCT06697301 · EU 2024-512659-19-00 - 2. fázisNot yet taking people in NémetországPHOENIX - ECP: Extracorporeal PHotopheresis for immune-related cOlitis and/or hEpatitis in advanced melaNoma with inadequate response to steroId eXposure
- Where
- Berlin, Cologne, Dresden, Essen, Freiburg im Breisgau, Halle (Saale), Luebeck, Mainz, Mannheim, Munich
- Életkor
- 18 év and over
- People
- 46 worldwide
- Run by
- Therakos Europe Limited
See details and how to join2026-526261-14-00 - 3. fázisTaking peopleStudy to Investigate Lifileucel Regimen Plus Pembrolizumab Compared With Pembrolizumab Alone in Participants With Untreated Advanced Melanoma.
- Where
- Berlin, Dresden, Hamburg, Lübeck, Munich, Würzburg
- Életkor
- 18 év to 70 év
- People
- 670 worldwide
- Run by
- Iovance Biotherapeutics, Inc.
See details and how to joinNCT05727904 · EU 2022-503140-41-00 - 2. fázisTaking peopleEarly detection of side effects in patients with metastatic melanoma receiving immune checkpoint inhibitor therapy by investigation of the CD8+ immune infiltrate using [89Zr]Zr-Df-IAB22M2C-PET
- Where
- Tuebingen
- Életkor
- 18 év and over
- People
- 35
- Run by
- Universitaetsklinikum Tuebingen AöR
See details and how to join2024-512219-37-00 - 2. fázisTaking peopleNeoadjuvant Tebentafusp in Patients With Metastatic Uveal Melanoma
- Where
- Berlin
- Életkor
- 18 év and over
- People
- 19 worldwide
- Run by
- Grupo Español Multidisciplinar de Melanoma
See details and how to joinNCT07057596 · EU 2023-509076-42-00 - 2. fázisTaking peopleStudy of the Efficacy of Intratumoral L19IL2 or L19TNF or L19IL2/L19TNF, in Combination With Pembrolizumab, in Unresectable Melanoma Patients
- Where
- Essen, Freiburg im Breisgau, Kiel, Tuebingen
- Életkor
- 18 év and over
- People
- 162 worldwide
- Run by
- Philogen S.p.A.
See details and how to joinNCT06284590 · EU 2024-519326-20-00 - No phaseTaking peopleSocial Prescriptions and Micro-Learning to Improve Care for Cancer Patients and Their Support Persons
- Where
- Augsburg, Bayreuth, Berlin, Cologne, Erlangen, Regensburg, Würzburg
- Életkor
- 18 év and over
- People
- 384
- Run by
- University of Regensburg
See details and how to joinNCT07788729 - No phaseTaking peopleGustabor Phase 2 - Treating Taste Changes During Cancer Therapy: A Randomized Study Evaluating an AI- Based Nutrition Intervention
- Where
- Augsburg, Erlangen, München, Regensburg, Würzburg
- Életkor
- 18 év and over
- People
- 198
- Run by
- Wuerzburg University Hospital
See details and how to joinNCT07649681 - 1/2. fázisTaking peopleA Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors
- Where
- Dresden, Essen, Frankfurt, Ulm, Würzburg
- Életkor
- 18 év and over
- People
- 1109 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT04895709 - 1. fázisTaking peopleA First-in-Human Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of KUP-101A in Patients With Selected Advanced Solid Tumors
- Where
- Bochum, Cologne, Marburg, Muenster, Munich, Wuerzburg
- Életkor
- 18 év and over
- People
- 21
- Run by
- Kupando GmbH
See details and how to joinNCT07600476 · EU 2025-522402-21-00 - No phaseTaking peopleClinical Study on High-fiber Diet and Short-term Fasting in Melanoma Under Immunotherapy With Checkpoint Inhibition
- Where
- Berlin
- Életkor
- 18 év and over
- People
- 60
- Run by
- Charite University, Berlin, Germany
See details and how to joinNCT07680452 - 3. fázisTaking peopleVO and Nivolumab vs Physician's Choice in Advanced Melanoma That Progressed on Anti-PD-1 & Anti-CTLA-4 Drugs [IGNYTE-3]
- Where
- Berlin, Dresden, Erfurt, Essen, Frankfurt Am Main, Hamburg, Heidelberg, Kiel, Mainz, Munich, Tuebingen
- Életkor
- 12 év and over
- People
- 400 worldwide
- Run by
- Replimune, Inc.
See details and how to joinNCT06264180 · EU 2023-508612-29-00 - No phaseTaking peopleReducing Symptom Burden Through Physical Exercise in Melanoma Patients
- Where
- Essen
- Életkor
- 18 év and over
- People
- 86
- Run by
- Universität Duisburg-Essen
See details and how to joinNCT06985056 - 3. fázisTaking peopleAdjuvant Tebentafusp in High Risk Ocular Melanoma
- Where
- Berlin, Essen, Hamburg, Heidelberg
- Életkor
- 18 év and over
- People
- 290 worldwide
- Run by
- European Organisation for Research and Treatment of Cancer - EORTC
See details and how to joinNCT06246149 · EU 2023-510333-28-00 - 1/2. fázisTaking peopleACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors
- Where
- Berlin, Bonn, Dresden, Hamburg, Heidelberg, Mainz, Munich, Würzburg
- Életkor
- 18 év and over
- People
- 375 worldwide
- Run by
- Immatics US, Inc.
See details and how to joinNCT03686124